Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 16, 2021; 9(35): 10899-10908
Published online Dec 16, 2021. doi: 10.12998/wjcc.v9.i35.10899
Table 1 Baseline characteristics

Mg2+ (mg/dL)
P value
AKI, n = 85
Non-AKI, n = 148
P value
< 0.755 mg/dL, n = 87
≥ 0.755 mg/dL, n = 146
Age, yr39 (32, 52)44 (34, 58)0.063 38 (30, 50)44.5 (35.5, 54.5)0.011
Gender, male, n (%)59 (67.8)98 (67.1)0.913 59 (69.4)98 (66.2)0.913
BMI27.1 (24.7, 30.1)25.6 (23.9, 28.1)0.028 27.6 (24.8, 30.7)25.4 (23.4, 27.7)< 0.001
APACHE II9 (7, 12)7 (5, 9)0.002 11 (8, 14)7 (4, 9)< 0.001
SOFA3 (3, 4)3 (2, 4)0.075 4 (3, 5)3 (2, 4)< 0.001
CTSI6 (3, 6)5 (3, 6)0.122 6 (6, 6)4 (2, 6)< 0.001
Severity classification, n (%)0.064 < 0.001
MAP21 (24.1)50 (34.2)7 (8.2)64 (43.2)
MSAP47 (54.0)79 (54.1)45 (53.0)81 (54.7)
SAP19 (21.8)17 (11.6)33 (38.8)3 (2.1)
Comorbidities
Diabetes23 (26.4)24 (16.4)0.066 20 (23.5)27 (18.2)0.066
Hypertension22 (25.3)36 (24.7)0.914 22 (25.9)36 (24.3)0.914
Hyperlipidemia25 (28.7)36 (24.7)0.493 21 (24.7)40 (27.0)0.493
Laboratory data
WBC13.4 (10.6, 16.6)12.8 (10.1, 15.7)0.336 12.9 (10.9, 16.6)12.9 (10.3, 16.1)0.685
Ly%8.1 (5.1, 11.2)6.7 (4.7, 10.6)0.297 6.9 (4.9, 10.5)7.2 (5, 11.2)0.769
IL-6199.6 (104.8, 366.4)115.4 (45.4, 201.5)< 0.001222.8 (130.4, 370)104.8 (45.4, 178.4)< 0.001
PCT1.2 (0.4, 3.3)0.4 (0.1, 1.6)< 0.0012.1 (1.1, 7.7)0.3 (0.1, 0.8)< 0.001
Platelets193 (142, 238)174 (134, 224)0.215 199 (132, 236)176.5 (142, 218)0.248
BUN5.4 (3.7, 6.3)5.1 (4, 6.9)0.576 6 (4, 8.3)4.8 (3.8, 5.9)< 0.001
Creatinine61 (49, 8)63 (53, 8)0.924 50 (41, 57.3)51 (46, 59)0.184
HCO3-18.9 (15.1, 23.5)22 (18.7, 24.2)< 0.00117.8 (13.7, 21.3)22.6 (19.8, 24.7)< 0.001
Cl-103 (99, 105)102 (100, 105)0.825 103.7 (101, 107)102 (99, 104)< 0.001
Mg2-0.7 (0.6, 0.7)0.885 (0.8, 0.9)< 0.001